Drug Approval | July 18, 2025
Lupin receives Form 483 with 4 observations from USFDA for Pithampur unit-2
The company is addressing these observations comprehensively
The company is addressing these observations comprehensively
The receipt of EIR reaffirms the company's commitment to maintaining global quality standards
Commercial production is expected to begin soon
The inspection concluded with zero Form 483 observations
BASF strengthens its commitment to the biopharma and pharmaceutical ingredients industries through a new investment in North America
The 16,000-square-foot expansion enhances DuPont’s global sterile operations
Allopurinol is used to prevent or lower high uric acid levels in the blood
Certification bolsters Venus Remedies' position in PIC/S markets, reinforcing commitment to global quality standards
The CDMO upgrade represents a transformational step for Remedium Lifecare
he inspection covering the sterile drug product filling and packaging line, quality systems and quality control laboratories concluded compliance with the principles and guidelines of Good Manufacturing Practice
Subscribe To Our Newsletter & Stay Updated
